Innovation in TargetED Therapy
Program
Friday May 6th 2022
09.00 - 09.10 Welcome
Session of new target for disease's treatment and diagnosis
09.10 - 09.55 Lecture: IL-3...bejond hematopoiesis and inflammation, Prof. Maria Felice Brizzi, Department of Medical Science, University of Turin
09.55 - 10.15 The Hippo effector TAZ cooperates with oncogenic β-Catenin to induce Hepatoblastoma development in mice and humans, Dr Antonio Cigliano, University of Regensburg and University of Sassari
10.15 - 10.35 Plasma analysis of polyamines metabolome by liquid chromatography– tandem mass spectrometry in Prostate Cancer, Coradduzza Donatella, University of Sassari
10.35 - 10.55 Emergence of mismatch repair deficiency and increased mutational burden in tumor and blood of colorectal cancer patients treated with temozolomide, Dr Giovanni Crisafulli, University of Torino, and Candiolo Cancer Institute
10.55 - 11.15 KRAS mutations in Italian patients with non – small cell lung cancer: clues from Sardinia, Dr Panagiotis Paliogiannis, University of Sassari, and Anatomic Pathology and Histology, University Hospital of Sassari
11.15 - 11. 30 Break
Session of novel pharmacological approaches to the disease's treatment
11.30 – 12.15 Lecture: Surface functionalisation of red blood cells derived extracellular vesicles for targeted-specific deliver of therapeutics, Dr Marco Pirisinu, Department of Biomedical Sciences, College of Veterinary Medicine and Life Sciences, City , University of Hong Kong
12.15 - 12.35 A network-based algorithm that predicts targets for the therapeutic intervention of Esophageal Squamous Cell Carcinoma, Dr. Kyle Vaughn Laster, China-US (Henan) Hormel Cancer Institute
12.35 - 12.55 Engineering Nanobody‐Based Therapeutics Toward Next Generation Immunotherapies, Dr. Likun Wei, City University of Hong Kong and Jotbody (HK) Limited
12.55 - 13.15 Nanoparticle-mediated delivery of a new TSPO ligand suppresses inflammation in LPS-stimulated microglia and in a mouse model of Alzheimer’s disease, Dr. Antonella Casamassa,, School of Medicine, University of Naples
13.15 - 13.35 2-Pentadecyl-2-Oxazoline restores cognitive and social behaviour impairments in a soluble Amyloid β-induced Alzheimer-like mice model, Dr. Rosmara Infantino,, University of Campania
13.35 - 15.00 Lunch & Poster Session
Session of drug delivery systems for targeted therapy
15.00 - 15.45 Lecture: Harnessing the antibacterial properties of fluoridated chitosan polymers against oral biofilms, Dr Marta Roldo, Reader in Biomaterials, School of Pharmacy and BMS, University of Portsmouth
15.45 - 16.05 Applications of nanoparticles drugs in gastrointestinal diseases, Prof. Ana Alcudia, Universidad de Sevilla
16.05 - 16.25 3D-printed implantable devices with biodegradable rate-controlling membrane for sustained delivery of hydrophobic drugs, Camila J. Picco, School of Pharmacy, Queen’s University Belfast
16.25 - 16.45 Biopolymeric microparticles sintered and infiltrated in porous titanium as a bioactive strategy and for the controlled release of drugs, Dr Francesca Accioni, University of Sevilla
16.45 - 17.05 Development of hybrid hydrogels for osteochnodral regeneration, Tosca Roncada, University of Portsmouth
17.05 - 17.15 Final remarks
Please note that the sessions will take place according to Central European Summer Time (CEST)
with the patronage
